Virtus Investment Advisers, Inc. Immunity Bio, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 139,309 shares of IBRX stock, worth $344,093. This represents 0.13% of its overall portfolio holdings.
Number of Shares
139,309
Previous 118,100
17.96%
Holding current value
$344,093
Previous $355,000
3.38%
% of portfolio
0.13%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding IBRX
# of Institutions
260Shares Held
87.7MCall Options Held
1.09MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA21.8MShares$53.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.2 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$18.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA5.78MShares$14.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$8.51 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $989M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...